1. Home
  2. VKTX vs GBTG Comparison

VKTX vs GBTG Comparison

Compare VKTX & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • GBTG
  • Stock Information
  • Founded
  • VKTX 2012
  • GBTG 2014
  • Country
  • VKTX United States
  • GBTG United States
  • Employees
  • VKTX N/A
  • GBTG N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • GBTG Computer Software: Prepackaged Software
  • Sector
  • VKTX Health Care
  • GBTG Technology
  • Exchange
  • VKTX Nasdaq
  • GBTG Nasdaq
  • Market Cap
  • VKTX 2.8B
  • GBTG 2.9B
  • IPO Year
  • VKTX 2015
  • GBTG N/A
  • Fundamental
  • Price
  • VKTX $28.14
  • GBTG $6.39
  • Analyst Decision
  • VKTX Buy
  • GBTG Strong Buy
  • Analyst Count
  • VKTX 12
  • GBTG 4
  • Target Price
  • VKTX $84.00
  • GBTG $9.63
  • AVG Volume (30 Days)
  • VKTX 3.9M
  • GBTG 1.4M
  • Earning Date
  • VKTX 07-23-2025
  • GBTG 08-05-2025
  • Dividend Yield
  • VKTX N/A
  • GBTG N/A
  • EPS Growth
  • VKTX N/A
  • GBTG N/A
  • EPS
  • VKTX N/A
  • GBTG N/A
  • Revenue
  • VKTX N/A
  • GBTG $2,434,000,000.00
  • Revenue This Year
  • VKTX N/A
  • GBTG $2.77
  • Revenue Next Year
  • VKTX N/A
  • GBTG $4.42
  • P/E Ratio
  • VKTX N/A
  • GBTG N/A
  • Revenue Growth
  • VKTX N/A
  • GBTG 4.82
  • 52 Week Low
  • VKTX $18.92
  • GBTG $5.78
  • 52 Week High
  • VKTX $81.73
  • GBTG $9.60
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 55.39
  • GBTG 55.88
  • Support Level
  • VKTX $25.80
  • GBTG $6.24
  • Resistance Level
  • VKTX $28.80
  • GBTG $6.53
  • Average True Range (ATR)
  • VKTX 1.65
  • GBTG 0.19
  • MACD
  • VKTX 0.11
  • GBTG 0.03
  • Stochastic Oscillator
  • VKTX 86.93
  • GBTG 89.19

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

Share on Social Networks: